By selecting "SUBMIT" and submitting this form, I confirm that I am over 18 years of age, and that I have reviewed and accepted the terms and conditions and privacy policy of LitigationNotification.com. I also agree to the disclosure of the information I provide on this website to legal and non-legal service providers, as well as partners, affiliates, and service providers. Moreover, I consent to receive communications, both human and/or AI-driven, via email and telephone, including SMS text messages by Litigation Notification and it’s partners, using the contact details I have provided, regardless of my inclusion of in the "Do not call" registry. I acknowledge that my agreement to receive messages is voluntary and if I choose not to receive communication, I will opt out where applicable or not submit this request.
Pfizer has voluntarily withdrawn the sickle cell treatment Oxbryta (voxelotor) from all markets in which it was approved after concluding “the overall benefit” of the drug “no longer outweighs the risk.”
Severe Side Effects: Oxbryta (voxelotor) has been linked to serious health risks, including organ damage and severe reactions.
Fatalities Reported: Some patients have tragically lost their lives due to complications from the drug.
FDA Withdrawal: The FDA recently withdrew Oxbryta after studies revealed its risks outweigh the benefits for sickle cell patients.
Pfizer has voluntarily withdrawn the sickle cell treatment Oxbryta (voxelotor) from all markets in which it was approved after concluding “the overall benefit” of the drug “no longer outweighs the risk.”
Severe Side Effects: Oxbryta (voxelotor) was intended to prevent serious complications of sickle cell disease but may increase the risk of a vaso-occlusive crisis and death
Fatalities Reported: Reuters reported that in a recent study of 236 people, there were eight deaths among patients taking Oxbryta.
FDA Withdrawal: The FDA recently withdrew Oxbryta after studies revealed its risks outweigh the benefits for sickle cell patients.
Repeated uncontrollable vomiting: A distressing symptom that can affect daily life and overall well-being.
Impaired digestion: Difficulty or inability to digest standard amounts of food, leading to discomfort.
Malnutrition: A consequence of the body's inability to absorb necessary nutrients.
Stomach pain: Chronic or intermittent pain that can be debilitating.
Burning sensation in the esophagus: A painful symptom that can impact eating and sleep patterns.
Efficient Case Evaluation: Our streamlined process ensures a quick and comprehensive review of your case, allowing you to understand your legal position without any unnecessary delays.
Nationwide Support: Regardless of where you reside, our dedicated team offers unwavering assistance across all 50 states, ensuring you're never alone in this journey.
Risk-Free Representation: We firmly believe in the strength and validity of your case. Therefore, there are absolutely no costs to file your case unless we achieve a victory on your behalf.
Personalized Legal Approach: The multidistrict litigation (MDL) process means you're not just another number in a large class action. Instead, you receive individualized attention, ensuring your unique circumstances and needs are prioritized.
Sickle cells can’t move easily and often cause blockages, which may lead to a vaso-occlusive crisis. This event is accompanied by moderate or acute pain. Potential symptoms and complications include:
You may be entitled to compensation for medical expenses, surgical costs, pain and suffering, and any long-term effects caused by the Oxbryta's complications.